.
In general, the specific activities ofthe mammalian CA III isozymes tend to be lower than those of the CA I and CA II isozymes and are much less sensitive to inhibition by sulfonamides than are CA I and CA II activities (Sanyal et al., 1982) . CA III is readily extracted from skeletal muscle tissue in buffers of low ionic strength. This is also true for several enzymes of the glycolytic pathway (Lebherz et al., 1982) . These enzymes have therefore been referred to as "soluble" on "cytoplasmic." These terms may be somewhat misleading, since it has been demonstrated that sev-rations did not show any detectable CA III associated with this structure.
In addition to quantification of the immunogold labeling, CA III activity and content were assayed in the post-mitochondrial supernatant ofthe three muscles. In the SOL, these values were found to be 3.6-7.6 times higher than in the DVL. The SVL showed a labeling inten- CA III was detected on the nitrocellulose using a CA Ill-specific antibody which has been previously characterized (Fr#{233}mont et al., 1987; Carter et al., 1981) and 125I ; . .
:..t (.: Figure  1A) . Figure  4D , lane 1), and traces of the enzyme were detected after the first wash ( Figure  4D, lane 2) , but no reaction with the CA III antiserum was observed in the following three pellets ( Figure 4D, lanes 3-5) . Immunochemical quantification of CA III in the corresponding supernatants ( Figure  4B) showed that more than 99% of total cellular CA III is found in 
